4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-050675
CEO and Chairman of the Board sold 10,000 shares at $1.62 ($16,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Camaisa Allan CEO and Chairman of the Board | 2024-12-17 | Sale | −10,000 | $1.62 | $16,200 | 66,712 | D |
| Open-market sales · 10,000 sh · avg $1.62 · $16,200 | |||||||
Loading xslF345X05/ownership.xml…